Recent Broad Publications
- Hopping between Differentiation States in Lung Adenocarcinoma.
Read More / View Supplemental Materials - Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system.
Read More / View Supplemental Materials - The Genome of Anopheles darlingi, the main neotropical malaria vector.
Read More / View Supplemental Materials - ATHLATES: accurate typing of human leukocyte antigen through exome sequencing.
Read More / View Supplemental Materials - Integrated proteomic analysis of post-translational modifications by serial enrichment.
Read More / View Supplemental Materials
Scientific Publications
< Back to Publications
Low Plasma Level of Atrial Natriuretic Peptide Predicts Development of Diabetes: The Prospective Malmo Diet and Cancer Study.
| Publication Type | Journal Article |
| Authors | Magnusson, M., Jujic A., Hedblad B., Engström G., Persson M., Struck J., Morgenthaler NG, Nilsson P., Newton-Cheh C., Wang TJ, and Melander O. |
| Abstract | Context:The cardiac natriuretic peptides are involved in blood pressure regulation, and large cross-sectional studies have shown lower plasma levels of N-terminal pro-natriuretic peptide levels [N-terminal atrial natriuretic peptide (N-ANP) and N-terminal brain natriuretic peptide (N-BNP)] in patients with insulin resistance, obesity, and diabetes.Objective:In this study, we prospectively tested whether plasma levels of mid-regional ANP (MR-ANP) and N-BNP predict new-onset diabetes and long-term glucose progression.Design, Setting, and Patients:MR-ANP and N-BNP were measured in 1828 nondiabetic individuals of the Malmö Diet and Cancer cohort (mean age 60 yr; 61% women) who subsequently underwent a follow-up exam including an oral glucose tolerance test after a median follow-up time of 16 yr. Logistic regression was used to adjust for covariates.Results:During follow-up, 301 subjects developed new-onset diabetes. After full multivariate adjustment, MR-ANP was significantly inversely associated with incident diabetes (OR = 0.85; 95% CI = 0.73-0.99; P = 0.034) but not N-BNP (OR = 0.92; 95% CI = 0.80-1.06; P = 0.262). In fully adjusted linear regression models, the progression of fasting glucose during follow-up was significantly inversely related to baseline levels of MR-ANP (P = 0.004) but not N-BNP (P = 0.129). Quartile analyses revealed that the overall association was mainly accounted for by excess risk of incident diabetes in subjects belonging to the lowest quartile of MR-ANP. After full adjustment, the odds ratio for incident diabetes in the bottom compared with the top quartile of MR-ANP was 1.65 (OR = 1.08-2.51, P = 0.019) and 1.43 (OR = 1.04-1.96, P = 0.027) compared with all other subjects.Conclusion:Low plasma levels of MR-ANP predict development of future diabetes and glucose progression over time, suggesting a causal role of ANP deficiency in diabetes development. |
| Year of Publication | 2011 |
| Journal | The Journal of clinical endocrinology and metabolism |
| Date Published (YYYY/MM/DD) | 2011/11/23 |
| ISSN Number | 0021-972X |
| DOI | 10.1210/jc.2011-2425 |
| PubMed | http://www.ncbi.nlm.nih.gov/pubmed/22112816?dopt=Abstract |
Share This
- Tweet
